Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ahles TA, Saykin AJ (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7: 192–201.
Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS et al. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of age and cognitive reserve. J Clin Oncol (in press).
de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FSAM, Nederveen AJ et al (2010). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapping (in press); e-pub ahead of print 28 July 2010, at http://onlinelibrary.wiley.com/doi/10.1002/hbm.21102/pdf.
Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J (2005). A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104: 2222–2233.
McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat (in press); e-pub ahead of print 6 August 2010, at http://www.springerlink.com/content/5686768t1q25287p/fulltext.pdf.
Meyers CA, Perry JR (eds) (2008). Cognition and Cancer. Cambridge University Press: Cambridge, MA.
Acknowledgements
The work described here was supported in part by National Cancer Institute Grants 5R01CA087845 and 5R01CA101318.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
PowerPoint slides
Rights and permissions
About this article
Cite this article
McDonald, B., Saykin, A. Neurocognitive Dimensions of Breast Cancer and Its Treatment. Neuropsychopharmacol 36, 355–356 (2011). https://doi.org/10.1038/npp.2010.142
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2010.142
